AlertEdge.io
Single-Ticker Trade Brief
IDXX — Idexx Laboratories Report Date: 2026-08-04 14:38 UTC  |  Sector: Health Care  |  Rating:
RISK DISCLAIMER: This is an automated breakout signal. Always validate before entering a position.
▲ Breakout Signal — Volume Confirmed

IDXX closed above the $580.37 breakout level on 2.4x average volume. ATR-based levels set automatically. Next resistance target: $627.2.

Ticker
IDXX
Entry Price
$590.42
Breakout Level
$580.37
Stop Loss
$561.98
TP1 Target
$627.2
TP2 Target
$651.72
Risk / Reward
1 : 1.29
2.4x avg volume
View IDXX Chart on TradingView

Key Price Levels

TP1 Target
$627.2
Breakout Level
$580.37
Entry
$590.42
Stop Loss
$561.98

Fundamentals

P/E Ratio
42.776447
EPS (TTM)
13.8
Dividend Yield
0.0%
52-Wk High
769.98
52-Wk Low
518.55
Beta
1.542

Deep Dive Analysis — Claude Sonnet

ALERTEDGE TRADE BRIEF — IDXX (Idexx Laboratories)

Generated at $590.32 | Signal Score: 50/100

SETUP

IDXX broke cleanly above the $580.37 level on 2.4x average volume, confirming real buying interest behind the move. Price gapped open significantly from the prior close of $573.63 and is holding near the breakout zone. The current bar shows a wide range with the low sitting right at the breakout level, meaning price tested and held. However, the live price is near the low of the session bar, suggesting intraday sellers pushed back after the initial gap. The stock is still well off its 52-week high of $769.98, leaving meaningful room to recover if momentum continues. The R/R of 1:1.29 is modest but acceptable given the clean technical structure.

CATALYSTS

IDXX just posted a Q2 beat with EPS of $2.96 versus $2.85 estimated, and the company raised its full-year outlook, which is the direct driver of today's gap. This marks five consecutive earnings beats, demonstrating consistent fundamental execution. The veterinary diagnostics space benefits from secular tailwinds as pet ownership and pet healthcare spending remain resilient even in softer economic environments. Broad equity futures strength tied to Strait of Hormuz re-opening hopes is adding a macro tailwind to the session.

RISKS

The signal quality score of 50/100 flags this as a post-earnings gap entry, meaning much of the immediate news is already priced in. The stock is trading 23% below its 52-week high, indicating a broader downtrend that a single earnings pop does not erase. Beta of 1.54 means IDXX will amplify any broader market selloff. The next earnings date is not until August 2026, so there is no near-term catalyst to sustain momentum beyond today. P/E of 42.8 leaves limited margin for error if macro conditions deteriorate. Insider activity shows only small equity award acquisitions, not meaningful open-market buying.

CONVICTION: Medium

The earnings beat and raised guidance justify the breakout, but the post-gap entry, extended distance from the 52-week high, and modest R/R cap the confidence level on this setup.

Entry: $590.42 | Stop: $561.98 | TP1: $627.20 | TP2: $651.72